» Articles » PMID: 38994023

The CEBPB Glioblastoma Subcluster Specifically Drives the Formation of M2 Tumor-associated Macrophages to Promote Malignancy Growth

Overview
Journal Theranostics
Date 2024 Jul 12
PMID 38994023
Authors
Affiliations
Soon will be listed here.
Abstract

The heterogeneity of tumor cells within the glioblastoma (GBM) microenvironment presents a complex challenge in curbing GBM progression. Understanding the specific mechanisms of interaction between different GBM cell subclusters and non-tumor cells is crucial. In this study, we utilized a comprehensive approach integrating glioma single-cell and spatial transcriptomics. This allowed us to examine the molecular interactions and spatial localization within GBM, focusing on a specific tumor cell subcluster, GBM subcluster 6, and M2-type tumor-associated macrophages (M2 TAMs). Our analysis revealed a significant correlation between a specific tumor cell subcluster, GBM cluster 6, and M2-type TAMs. Further in vitro and in vivo experiments demonstrated the specific regulatory role of the CEBPB transcriptional network in GBM subcluster 6, which governs its tumorigenicity, recruitment of M2 TAMs, and polarization. This regulation involves molecules such as MCP1 for macrophage recruitment and the SPP1-Integrin αvβ1-Akt signaling pathway for M2 polarization. Our findings not only deepen our understanding of the formation of M2 TAMs, particularly highlighting the differential roles played by heterogeneous cells within GBM in this process, but also provided new insights for effectively controlling the malignant progression of GBM.

References
1.
Aguilar-Morante D, Cortes-Canteli M, Sanz-Sancristobal M, Santos A, Perez-Castillo A . Decreased CCAAT/enhancer binding protein β expression inhibits the growth of glioblastoma cells. Neuroscience. 2010; 176:110-9. DOI: 10.1016/j.neuroscience.2010.12.025. View

2.
Ren X, Zhang L, Zhang Y, Li Z, Siemers N, Zhang Z . Insights Gained from Single-Cell Analysis of Immune Cells in the Tumor Microenvironment. Annu Rev Immunol. 2021; 39:583-609. DOI: 10.1146/annurev-immunol-110519-071134. View

3.
Tao W, Chu C, Zhou W, Huang Z, Zhai K, Fang X . Dual Role of WISP1 in maintaining glioma stem cells and tumor-supportive macrophages in glioblastoma. Nat Commun. 2020; 11(1):3015. PMC: 7295765. DOI: 10.1038/s41467-020-16827-z. View

4.
Wen P, Kesari S . Malignant gliomas in adults. N Engl J Med. 2008; 359(5):492-507. DOI: 10.1056/NEJMra0708126. View

5.
Yabo Y, Niclou S, Golebiewska A . Cancer cell heterogeneity and plasticity: A paradigm shift in glioblastoma. Neuro Oncol. 2021; 24(5):669-682. PMC: 9071273. DOI: 10.1093/neuonc/noab269. View